F8 and hemophilia: The recommended dose, administered by intravenous bolus injection, is 15–30 μg/kg of body mass every 4–6 h [20], while, in hemophilia and FVIII inhibition, rFVIIa should be administered in the dose of 90 μg/kg of body mass, initially every 2–3 h.